Omeros Co. (NASDAQ:OMER) – Research analysts at Wedbush increased their Q1 2020 EPS estimates for shares of Omeros in a research note issued on Monday, April 27th. Wedbush analyst L. Moussatos now e
In a report released today, Liana Moussatos from Wedbush reiterated a Hold rating on Omeros (OMER), with a price target of $17.00. The company's shares
In a report released today, Liana Moussatos from Wedbush reiterated a Hold rating on Omeros ( OMER – Research Report ), with a price target of $17.00 . The company’s shares closed last Monday at $
Nuveen Asset Management LLC decreased its position in Omeros Co. (NASDAQ:OMER) by 2.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 199,819 shares of the
Omeros (NASDAQ:OMER) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday, BidAskClub reports. Several other analys
Bank of America Corp DE reduced its position in shares of Omeros Co. (NASDAQ:OMER) by 10.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Bank of New York Mellon Corp boosted its holdings in shares of Omeros Co. (NASDAQ:OMER) by 3.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Comm
Omeros (NASDAQ:OMER) and Advaxis (NASDAQ:ADXS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profi
Nwam LLC reduced its position in shares of Omeros Co. (NASDAQ:OMER) by 10.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission
Brokerages predict that Omeros Co. (NASDAQ:OMER) will report earnings per share of ($0.43) for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Omeros’ earnings. The
Equities research analysts predict that Omeros Co. (NASDAQ:OMER) will report sales of $30.92 million for the current quarter, according to Zacks Investment Research. Two analysts have provided estimat
Cypress Capital Group increased its position in shares of Omeros Co. (NASDAQ:OMER) by 13.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional
Omeros Co. (NASDAQ:OMER) has received an average recommendation of “Buy” from the eight analysts that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst ha
Baird Financial Group Inc. purchased a new stake in shares of Omeros Co. (NASDAQ:OMER) during the 4th quarter, Holdings Channel.com reports. The fund purchased 12,200 shares of the biopharmaceutical c
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE